Exploring the antimicrobial and cytotoxic potential of novel chloroquine analogues

References

• Gao J, Hou H, Gao F. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens. Eur. J. Med. Chem. 21, 115026 (2023).
   Google Scholar
• Ibrahim TS, Malebari AM, Mohamed MF. Design, synthesis, in vitro anti-cancer evaluation and molecular modelling studies of 3,4,5-trimethoxyphenyl-based derivatives as dual EGFR/HDAC hybrid inhibitors. Pharmaceuticals 14(11), 1–21 (2021).
   Web of Science ®Google Scholar
• Akkachairin B, Rodphon W, Reamtong O et al. Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anti-cancer and antiplasmodial activities. Bioorg. Chem. 98, 103732 (2020).
   PubMed Web of Science ®Google Scholar
• Nematpour M, Rezaee E, Nazari M, Hosseini O, Tabatabai SA. Targeting EGFR tyrosine kinase: design, synthesis and biological evaluation of novel quinazolinone derivatives. Iran. J. Pharm. Res. 21(1), 1–13 (2022).
   Web of Science ®Google Scholar
• Ma Y, Wang YR, He YH et al. Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads. J. Antibiot. 76(1), 27–51 (2023).
   PubMed Web of Science ®Google Scholar
• Murugavel S, Stephen CJP, Subashini R, AnanthaKrishnan D. Synthesis, structural elucidation, antioxidant, CT-DNA binding and molecular docking studies of novel chloroquinoline derivatives: promising antioxidant and anti-diabetic agents. J. Photochem. Photobiol. B Biol. 173, 216–230 (2017).
   PubMed Web of Science ®Google Scholar
• Matada BS, Pattanashettar R, Yernale NG. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg. Med. Chem. 32, 1–25 (2021).
   Web of Science ®Google Scholar
• Raynes K, Foley M, Tilley L, Deady LW. Novel bisquinoline antimalarials: synthesis, antimalarial activity, and inhibition of haem polymerisation. Biochem. Pharmacol. 52(4), 551–559 (1996).
   PubMed Web of Science ®Google Scholar
• Chibale K, Moss JR, Blackie M, Schalkwyk D, Smith PJ. New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studies. Tetrahedron Lett. 41(32), 6231–6235 (2000).
   Web of Science ®Google Scholar
• Bawa S, Kumar S, Drabu S, Kumar R. Structural modifications of quinoline-based antimalarial agents: recent developments. J. Pharm. Bioallied Sci. 2(2), 64 (2010).
   PubMedGoogle Scholar
• Özyanik M, Demirci S, Bektaş H, Demirbaş N, Demirbaş A, Karaoğlu ŞA. Preparation and antimicrobial activity evaluation of some quinoline derivatives containing an azole nucleus. Turk. J. Chem. 36(2), 233–246 (2012).
   Web of Science ®Google Scholar
• Graves PR, Kwiek JJ, Fadden P et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol. Pharmacol. 62(6), 1364–1372 (2002).
   PubMed Web of Science ®Google Scholar
• Kaschula CH, Egan TJ, Hunter R et al. Structure–activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J. Med. Chem. 45(16), 3531–3539 (2002).
   PubMed Web of Science ®Google Scholar
• Pham TD, Ziora ZM, Blaskovich MA. Quinolone antibiotics. MedChemComm. 10(10), 1719–1739 (2019).
   PubMed Web of Science ®Google Scholar
• Islam S, Shahzad SA, Asad MHHB, Mannan A. Novel amodiaquine analogues to treat cervical cancer and microbial infection in the future. Future Med. Chem. 15(23), 2165–2179 (2023).
   PubMed Web of Science ®Google Scholar
• Katariya KD, Shah SR, Reddy D. Anti-cancer, antimicrobial activities of quinoline based hydrazone analogues: synthesis, characterisation and molecular docking. Bioorg. Chem. 94, 103406 (2019).
   PubMed Web of Science ®Google Scholar
• Srivastava V, Hoyun L. Chloroquine-based hybrid molecules as promising novel chemotherapeutic agents. Eur. J. Pharmacol. 762, 472–486 (2015).
   PubMed Web of Science ®Google Scholar
• Pavić K, Rajić Z, Mlinarić Z, Uzelac L, Kralj M, Zorc B. Chloroquine urea derivatives: synthesis and antitumor activity in vitro. Acta Pharm. 68(4), 471–483 (2018).
   PubMed Web of Science ®Google Scholar
• Solomon VR, Changkun H, Hoyun L. Design and synthesis of chloroquine analogs with anti-breast cancer property. Eur. J. Med. Chem. 45, 3916–3923 (2010).
   PubMed Web of Science ®Google Scholar
• Ali JS, Riaz N, Mannan A, Tabassum S, Zia M. Antioxidative-, antimicrobial-, enzyme inhibition-, and cytotoxicity-based fractionation and isolation of active components from Monotheca buxifolia (Falc.) A. DC. stem extracts. ACS Omega 7(4), 3407–3423 (2022).
   PubMed Web of Science ®Google Scholar
• Ovung A, Bhattacharyya J. Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys. Rev. 13(2), 259–272 (2021).
   PubMedGoogle Scholar
• Islam MN, Shahriar SMS, Islam MK, Jesmin M. Antibacterial activities of some transition metal Schiff base complexes. Int. Lett. Chem. Phys. Astron. 5, 12–20 (2013).
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65(12), 55–63 (1983).
   PubMedGoogle Scholar
• Huda NU, Islam S, Zia M et al. Anti-cancer, antimicrobial and antioxidant potential of sterically tuned bis-N-heterocyclic salts. Z. Naturforsch. C J. Biosci. 74(1–2), 17–23 (2018).
   PubMed Web of Science ®Google Scholar
• Sriram D, Yogeeswari P, Basha JS, Radhab DR, Nagaraja V. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg. Med. Chem. 13, 5774–5778 (2005).
   PubMed Web of Science ®Google Scholar
• Shabbir H, Riaz S, Rehman H et al. Synthesis, structural elucidation, and biological potential of novel sulfonamide drugs. Biosci. Rev. 4, 45–56 (2022).
   Google Scholar
• Türe A, Kulabas N, Dingis SI et al. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents. Bioorg. Chem. 88, 102965 (2019).
   PubMed Web of Science ®Google Scholar
• Zoete V, Daina A, Bovigny C, Michielin O. SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening. J Chem Inf Model. 56(8), 1399–1404 (2016).
   PubMed Web of Science ®Google Scholar
• Pence HE, Williams A. ChemSpider: an online chemical information resource. J. Chem. Educ. 87(11), 1123–1124 (2010).
   Web of Science ®Google Scholar
• Khamkhenshorngphanuch T, Kulkraisri K, Janjamratsaeng A et al. Synthesis and antimicrobial activity of novel 4-hydroxy-2-quinolone analogs. Molecules 25(13), 3059 (2020).
   PubMed Web of Science ®Google Scholar
• Abdi B, Fekadu M, Zeleke D, Eswaramoorthy R, Melaku Y. Synthesis and evaluation of the antibacterial and antioxidant activities of some novel chloroquinoline analogs. J. Chem. 2, 1–13 (2021).
   Google Scholar
• Rathod SV, Shinde KW, Kharkar PS, Shah CP. Synthesis, molecular docking and biological evaluation of new quinoline analogues as potent anti-breast cancer and antibacterial agents. Indian J. Chem. B 60(9), 1215–1222 (2021).
   Google Scholar
• Suresh K, Drabu S, Bibhu P, Rajiv K, Sandhya B. Synthesis and antimicrobial activity of 2-chloroquinoline incorporated pyrazoline derivatives. Pharm. Bioallied Sci. 1(1), 32 (2009).
   Google Scholar
• Khan KM, Saify ZS, Khan ZA et al. Syntheses and cytotoxic, antimicrobial, antifungal and cardiovascular activity of new quinoline derivatives. Drug Res. 50(10), 915–924 (2000).
   Web of Science ®Google Scholar
• Malghani Z, Khan AU, Faheem M et al. Molecular docking, antioxidant, anti-cancer and antileishmanial effects of newly synthesised quinoline derivatives. Anticancer Agents Med. Chem. 20(13), 1516–1529 (2020).
   PubMed Web of Science ®Google Scholar
• Shenghui W, Yongfeng G, Xiujuan L et al. Design, synthesis and anti-cancer activity studies of novel quinoline–indole derivatives. Chinese J. Org. Chem. 41(9), 3617–3624 (2019).
   Web of Science ®Google Scholar
• Ahsan MJ, Shastri S, Yadav R et al. Synthesis and antiproliferative activity of some quinoline and oxadiazole derivatives. Org. Chem. Int. 2, 1–10 (2016).
   Google Scholar
• Yadav DK, Reeta R, Naresh K et al. New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage. Sci. Rep. 6(October), 1–13 (2016).
   PubMedGoogle Scholar
• Gao Y, Shang Q, Li W. Antibiotics for cancer treatment: a double-edged sword. J. Cancer 11(17), 5135 (2020).
   PubMed Web of Science ®Google Scholar